196 related articles for article (PubMed ID: 36847838)
1. Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany.
Runnebaum IB; Kather A; Vorwergk J; Cruz JJ; Mothes AR; Beteta CR; Boer J; Keller M; Pölcher M; Mustea A; Sehouli J
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6953-6966. PubMed ID: 36847838
[TBL] [Abstract][Full Text] [Related]
2. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
[TBL] [Abstract][Full Text] [Related]
3. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
4. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
5. Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention.
Hanley GE; Pearce CL; Talhouk A; Kwon JS; Finlayson SJ; McAlpine JN; Huntsman DG; Miller D
JAMA Netw Open; 2022 Feb; 5(2):e2147343. PubMed ID: 35138400
[TBL] [Abstract][Full Text] [Related]
6. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
[TBL] [Abstract][Full Text] [Related]
7. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
[TBL] [Abstract][Full Text] [Related]
8. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
9. Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States.
Karia PS; Joshu CE; Visvanathan K
Cancer Prev Res (Phila); 2021 Dec; 14(12):1101-1110. PubMed ID: 34413116
[TBL] [Abstract][Full Text] [Related]
10. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
[TBL] [Abstract][Full Text] [Related]
11. Opportunistic salpingectomy for prevention of sporadic ovarian cancer - a jump from basic science to clinical practice?
Ziętek A; Bogusiewicz M; Szumiło J; Rechberger T
Ginekol Pol; 2016; 87(6):467-72. PubMed ID: 27418226
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Venkatesh KK; Clark LH; Stamilio DM
Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
Kotsopoulos J; Narod SA
Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528
[TBL] [Abstract][Full Text] [Related]
15. Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.
Darelius A; Kristjansdottir B; Dahm-Kähler P; Strandell A
Int J Cancer; 2021 Oct; 149(8):1544-1552. PubMed ID: 34152012
[TBL] [Abstract][Full Text] [Related]
16. Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO.
Pölcher M; Hauptmann S; Fotopoulou C; Schmalfeldt B; Meinhold-Heerlein I; Mustea A; Runnebaum I; Sehouli J
Arch Gynecol Obstet; 2015 Jul; 292(1):231-4. PubMed ID: 25914073
[TBL] [Abstract][Full Text] [Related]
17. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: A survey of current Australian practice.
Kapurubandara S; Qin V; Gurram D; Anpalagan A; Merkur H; Hogg R; Brand A
Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):606-11. PubMed ID: 26768958
[TBL] [Abstract][Full Text] [Related]
18. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
Hanley GE; McAlpine JN; Pearce CL; Miller D
Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
[TBL] [Abstract][Full Text] [Related]
19. Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology.
Mikami M; Nagase S; Yamagami W; Ushijma K; Tashiro H; Katabuchi H;
J Gynecol Oncol; 2017 Jul; 28(4):e52. PubMed ID: 28541639
[TBL] [Abstract][Full Text] [Related]
20. Beyond Sterilization: A Comprehensive Review on the Safety and Efficacy of Opportunistic Salpingectomy as a Preventative Strategy for Ovarian Cancer.
Zadabedini Masouleh T; Etchegary H; Hodgkinson K; Wilson BJ; Dawson L
Curr Oncol; 2023 Nov; 30(12):10152-10165. PubMed ID: 38132373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
